Uscom Ltd (UCM)
Australian Securities Exchange · Australia · prices in AUD · close of 22 Oct 2026
Key indicators
| Last close | AUD 0.012 |
|---|---|
| 52-week range | 0.012 – 0.012 |
| Return, 1 month / 3 months | +0.0% / +0.0% |
| Return, 1 year / 3 years | +0.0% / −70.0% |
| Trend | Below its 200-day average |
| RSI (14) | 72 |
| Volatility (1 year) | 0.0% |
| Worst drawdown (1 year) | 0.0% |
| Average daily value traded | 0.00M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Uscom Ltd designs and manufactures non-invasive cardiac monitoring devices that use ultrasound to measure blood flow and heart function. Its monitors help clinicians assess cardiac output and stroke volume without invasive procedures. The company serves hospitals, emergency departments and critical care settings, and it is based in Australia. Uscom also develops related monitoring technology for use in clinical and research environments.
The shares are listed on the Australian Securities Exchange in Australia under the code UCM, and the price on this page is in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Uscom Ltd (UCM) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.012 on 22 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 421 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.0% and over the last three months it rose 0.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 81 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 0.0% | ||
| From 52-week high | 0.0% | ||
| Momentum | 67 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 0.0% | ||
| 6-month return | 0.0% | ||
| 12-month return, skipping the last month | 0.0% | ||
| Stability (higher is calmer) | 99 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 0.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | 0.0% | ||
| Liquidity | 1 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M AUD | ||
| Zero-volume days | 100.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | +0.0% |
| 6 months | +0.0% |
| 1 year | +0.0% |
| 3 years | −70.0% |
| 5 years | −91.0% |
Signals
| 50-day / 200-day average | 0.012 / 0.012 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.000 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.